NCT04831788 is a clinical trial in Preference, Patient, sponsored by University of Novi Sad.

Who is sponsoring NCT04831788?

NCT04831788 is sponsored by University of Novi Sad.

What condition does NCT04831788 study?

NCT04831788 studies Preference, Patient.

Is NCT04831788 still recruiting?

NCT04831788 is currently completed. Last updated 1 November 2023.

Are results published for NCT04831788?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2023-11-01 · How we verify

NCT04831788

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pneumococcal Nasopharyngeal and Oropharyngeal Carriage in Adults

Completed Results posted Last updated 1 November 2023

What this trial tests

trial in Preference, Patient in 521 participants. Completed in 7 January 2022.

Timeline

2 June 2021

Primary endpoint
26 October 2021

7 January 2022

Quick facts

Lead sponsor	University of Novi Sad
Status	Completed
Study type	OBSERVATIONAL
Enrollment	521
Start date	2 June 2021
Primary completion	26 October 2021
Estimated completion	7 January 2022
Sites	1 location across Serbia

Conditions studied

Preference, Patient — all drugs for Preference, Patient →

Sponsor

University of Novi Sad

Who can join

Adults 50 to 100, any sex, with Preference, Patient. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Prevalence Primary · 90 days

Prevalence will be measured as a number of participants with positive isolates divided with overall number of participants analyzed and multiplied by a hundred to determine a percentage of positives

Group	Value	95% CI
Pneumococcal Nasopharyngeal and Oropharyngeal Carriage	16

Number of Participants With Spn Serotypes Secondary · 150 days

Serotype on NP and OP carriage with pneumococcal serotypes among adults older than 50 years of age in the city of Novi Sad according to specific clinical indications set for the PPV or PCV

Group	Value	95% CI
Pneumococcal Nasopharyngeal and Oropharyngeal Carriage	10
Pneumococcal Nasopharyngeal and Oropharyngeal Carriage	6

Sponsor's own description

This is the first baseline pilot-study that will evaluate the NP and OP colonization with the underline of pneumococcal serotype distribution among adults older than 50 years of age in Serbia and Southeastern Europe. Results of this project will serve as additional evidence in order to increase coverage among adults and elderly

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Preference, Patient

Currently open trials in the same condition.

NCT06046625 — Needs and Preferences of Patients With Head-neck Cutaneous SCC · active not recruiting

Other University of Novi Sad trials

Trials by the same sponsor.

NCT07491666 — Effects of Neuromuscular Exercises on Motor Skills in Girls · NA · active not recruiting
NCT07438171 — Maternal Satisfaction After Spinal Anesthesia for Cesarean Delivery · not yet recruiting
NCT07387575 — Screening in Relatives With Elevated Risk for Unruptured Intracranial Aneurysms · enrolling by invitation
NCT07098221 — Hydrogen-Rich Water and Resting Metabolism in Young Adults · NA · not yet recruiting
NCT07204886 — Impact of Multicomponent and Stability Training on Fitness and Function in Active Older Women · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04831788 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Novi Sad
Last refreshed: 1 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04831788.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing